MedPath
HSA Approval

Meropenem Mevon Powder for Solution for Injection or Infusion 1 g/vial

SIN14014P

Meropenem Mevon Powder for Solution for Injection or Infusion 1 g/vial

Meropenem Mevon Powder for Solution for Injection or Infusion 1 g/vial

September 19, 2011

NOVEM PHARMA PRIVATE LIMITED

NOVEM PHARMA PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM PHARMA PRIVATE LIMITED
Licence HolderNOVEM PHARMA PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS

Medical Information

J01DH02

meropenem

Manufacturer Information

NOVEM PHARMA PRIVATE LIMITED

ACS Dobfar S.p.A. 2

Demo S.A.

SAVIOR LIFETEC CORPORATION (sterile bulk)

SAVIOR LIFETEC CORPORATION Tainan Site (block A) (sterile bulk)

SAVIOR LIFETEC CORPORATION Tainan Site (block B) (sterile bulk)

ANFARM HELLAS S.A.

Active Ingredients

Meropenem trihydrate 1140 mg eqv. to anhydrous meropenem

1000 mg

Meropenem

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Meropenem Mevon Powder for Solution for Injection or Infusion 1 g/vial - HSA Approval | MedPath